News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Farzaneh-Far Ramin
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/03/2020 |
4
| Farzaneh-Far Ramin (Chief Medical Officer) has filed a Form 4 on Ra Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 14,492 shares
@ $48, valued at
$695.6k
Disposed/sold 11,110 options to buy
@ $5.6, valued at
$62.2k
Disposed/sold 73,654 options to buy
@ $5.6, valued at
$412.5k
Disposed/sold 90,000 options to buy
@ $16.64, valued at
$1.5M
Disposed/sold 62,500 options to buy
@ $7.33, valued at
$458.1k
Disposed/sold 133,000 options to buy
@ $21, valued at
$2.8M
Disposed/sold 10,416 restricted stock units
@ $0 |
|
| 03/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/20/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/16/2020 |
4
| Farzaneh-Far Ramin (Chief Medical Officer) has filed a Form 4 on Ra Pharmaceuticals, Inc.|
Txns:
| Sold 10,595 shares
@ $46.9505, valued at
$497.4k
Exercised 1,389 options to buy
@ $5.6, valued at
$7.8k
Exercised 9,206 options to buy
@ $5.6, valued at
$51.6k
|
|
| 12/18/2019 |
4
| Farzaneh-Far Ramin (Chief Medical Officer) has filed a Form 4 on Ra Pharmaceuticals, Inc.|
Txns:
| Sold 10,595 shares
@ $47.2252, valued at
$500.4k
Exercised 1,389 options to buy
@ $5.6, valued at
$7.8k
Exercised 9,206 options to buy
@ $5.6, valued at
$51.6k
|
|
| 11/18/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/17/2019 |
4
| Farzaneh-Far Ramin (Chief Medical Officer) has filed a Form 4 on Ra Pharmaceuticals, Inc.|
Txns:
| Sold 10,595 shares
@ $46.8871, valued at
$496.8k
Exercised 1,389 options to buy
@ $5.6, valued at
$7.8k
Exercised 9,206 options to buy
@ $5.6, valued at
$51.6k
|
|
| 09/16/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/27/2019 |
4
| Farzaneh-Far Ramin (Chief Medical Officer) has filed a Form 4 on Ra Pharmaceuticals, Inc.|
Txns:
| Sold 10,595 shares
@ $27.7703, valued at
$294.2k
Exercised 1,389 options to buy
@ $5.6, valued at
$7.8k
Exercised 9,206 options to buy
@ $5.6, valued at
$51.6k
|
|
| 07/16/2019 |
4
| Farzaneh-Far Ramin (Chief Medical Officer) has filed a Form 4 on Ra Pharmaceuticals, Inc.|
Txns:
| Sold 6,379 shares
@ $32.969, valued at
$210.3k
Sold 4,216 shares
@ $33.287, valued at
$140.3k
Exercised 1,389 options to buy
@ $5.6, valued at
$7.8k
Exercised 9,206 options to buy
@ $5.6, valued at
$51.6k
|
|
| 06/19/2019 |
4
| Farzaneh-Far Ramin (Chief Medical Officer) has filed a Form 4 on Ra Pharmaceuticals, Inc.|
Txns:
| Sold 3,411 shares
@ $21.4074, valued at
$73k
Sold 7,184 shares
@ $22.0439, valued at
$158.4k
Exercised 1,389 options to buy
@ $5.6, valued at
$7.8k
Exercised 9,206 options to buy
@ $5.6, valued at
$51.6k
|
|
| 02/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/05/2018 |
4
| Farzaneh-Far Ramin (Chief Medical Officer) has filed a Form 4 on Ra Pharmaceuticals, Inc.|
Txns:
| Granted 62,500 options to buy
@ $7.33, valued at
$458.1k
Granted 31,250 restricted stock units
@ $0 |
|
| 02/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/25/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
|
|